Powerock Pharma DIHEXA 10 mg 60 caps. 600 mg
DIHEXA intensifies cognitive functions and supports neuroplasticity through the activation of HGF/c-Met receptors – it enhances synaptogenesis and provides neuroprotection. Choose Powerock Pharma for guaranteed purity and proven research results.
DIHEXA 600 mg
DIHEXA is an advanced synthetic research peptide for the analysis of neurotrophic properties and studies on cognitive functions. This compound was designed with the aim of effectively supporting synaptogenesis and precise analysis of neuroprotective processes. Its action is based on mimicking and enhancing the activity of hepatocyte growth factor (HGF), a key element in neuron growth and regeneration processes. This specific functionality makes DIHEXA widely used in research on cognitive functions and nervous system health.
DIHEXA Powerock Pharma – Properties
Discover the potential laboratory properties of DIHEXA, which may support research on cognitive functions, neuroprotection, and nervous system health.
Support of Synaptogenesis
Supports the formation of new synaptic connections through activation of the HGF/c-Met pathway.
Neuroprotection
Protects neurons from age-related and degenerative damage.
Neuroplasticity
Optimizes brain plasticity and learning processes by supporting neuron regeneration.
Selective Mechanism
Specifically activates HGF/c-Met receptors, minimizing side effects.
Memory Enhancement
Supports memory consolidation and information retention processes in laboratory studies.
Long-Lasting Effects
Supports long-term neuron health without the risk of tolerance development.
High Research Quality
Manufactured according to GMP, HACCP, and ISO 13485 standards with purity ≥99.9%.
Precise Action
Targeted action on neurotrophic receptors for optimal research results.
Mechanism of Action of DIHEXA in Laboratory Conditions
- Activation of the HGF/c-Met pathway: DIHEXA binds to and activates HGF/c-Met receptors, key for neuron growth and repair processes in research models.
- Stimulation of synaptogenesis: This selective activation leads to increased formation of new synaptic connections in nerve tissues.
- Support of neuroplasticity: Helps optimize brain plasticity without relying on neurotransmitter modulation.
- Minimal off-target effects: The targeted mechanism ensures minimal adverse effects in laboratory studies.
- Support for long-term neuron health: An ideal candidate for research on neurodegenerative diseases and cognitive decline in animal models.
Why choose DIHEXA from Powerock Pharma?
At Powerock Pharma, our priority is to provide only the highest quality research substances. Every batch of DIHEXA is manufactured in facilities compliant with GMP, HACCP, and ISO 13485 standards. Our advanced HPLC tests guarantee purity ≥99.9%, and strict quality control supervision and the use of the most modern testing procedures ensure not only product effectiveness but also their safety and reliability. Cooperation with leading laboratories ensures purity and efficiency of substances, providing durable and repeatable results. By choosing Powerock Pharma, you choose excellence, safety, and unparalleled quality of research materials.
Research Protocol
Preparation method:
DIHEXA can be administered orally (in capsules) or via injection, depending on the specific requirements of the research protocol. For precise calculation of the amounts needed for studies, we recommend using the peptide dose calculator.
Administration schedule:
To ensure consistency and reliable data, it is recommended to administer DIHEXA at the same times each day throughout the research period.
Duration of a single research cycle:
A typical research cycle lasts 8–12 weeks, allowing sufficient time for observation and documentation of the compound’s effects on cognitive functions and neuroprotection.
Recommended amount for model A:
For research models of type A, the recommended starting dose is 5 mg per administration. Adjust according to study results and experimental goals.
Recommended amount for model B:
For research models of type B, a commonly used starting dose is 10 mg per administration. Adjust depending on the research design and results.
Monitoring:
Continuous monitoring of all research subjects is essential. Record behavioral, cognitive, and physiological responses, and respond immediately to any adverse events.
Frequently Asked Questions
- Typical research doses are 5 mg per administration for type A models and 10 mg for type B models, with adjustments based on study design and subject response.
- Yes, DIHEXA is often combined with other nootropics and neuroprotective agents for synergistic effects. Always ensure compatibility within the research protocol.
- Preclinical animal studies show minimal side effects, but as with any new compound, subjects should be closely monitored for unexpected reactions.
- Current preclinical data suggest good safety for extended research cycles, although all long-term effects should be carefully documented and reviewed.
- DIHEXA should be stored at controlled room temperature (below 25°C), protected from light and moisture to maintain stability and activity.
- Powerock Pharma products are manufactured in certified facilities, undergo rigorous HPLC purity and activity testing, and are trusted by researchers worldwide for their consistency and reliability.
Calculator for measuring research doses
Tip: 1 MG = 1000 MCG